Jeffrey Skolnik

Jeffrey Skolnik

Company: Inovio

Job title: Vice President Clinical Development

Seminars:

Inovio’s DNA Medicine for the Treatment of Glioblastoma 8:40 am

Using novel DNA-encoded medicines to treat human cancers such as GBM Generating robust, specific anti-tumor T cells against GBM antigens Combining DNA medicine with immune checkpoint inhibitors to build clinical responsesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.